Levade T, Gatt S, Salvayre R
Laboratoire de Biochimie, CHU Rangueil, Toulouse, France.
Biochem J. 1991 Apr 1;275 ( Pt 1)(Pt 1):211-7. doi: 10.1042/bj2750211.
Three fluorescent analogues of sphingomyelin (SPM), each containing pyrene in the fatty acyl residue, were synthesized and employed for the study of their mode of uptake by, and degradation within, intact cultured human skin fibroblasts. These were prepared by condensing sphingosylphosphocholine and the following fatty acids: pyrenedodecanoic acid (P12), pyrenesulphonylaminoundecanoic acid (PSA11) and pyrenepropenoic acid (P3:1). The cell association and catabolism of these SPM analogues by normal, Niemann-Pick-disease-Type-A and low-density-lipoprotein (LDL)-receptor-negative familial hypercholesterolaemia fibroblasts were investigated and compared with the metabolism of [cholinemethyl-14C]sphingomyelin. The catabolism of the fluorescent derivatives was monitored by measuring the appearance of the corresponding fluorescent ceramides. Two modes of uptake and degradation patterns were observed. Thus P12-SPM and radiolabelled SPM were taken up by LDL-receptor-mediated endocytosis when incubated with serum-containing medium, this conclusion being supported by the very low uptake by familial-hypercholesterolaemia fibroblasts, which lack the apolipoprotein-B/E receptor. After uptake, these compounds were metabolically degraded solely by the lysosomal sphingomyelinase, as evidenced by the fact that more than 98% of the SPM remained undegraded in Niemann-Pick-disease cells. By contrast, PSA11- and P3:1-SPMs were taken up by a receptor-independent endocytic pathway, as indicated by the similar rates of uptake in control and familial-hypercholesterolaemia cells in the absence or presence of fetal-calf serum in the culture medium. The degradation of PSA11-SPM and P3:1-SPM was brought about, in the main, by the lysosomal sphingomyelinase, but also by a yet uncharacterized process. The latter catabolic pathway, active in Niemann-Pick-disease-Type-A fibroblasts, seems to differ from the neutral Mg2(+)-dependent sphingomyelinase whose activity was undetectable in homogenates of skin fibroblasts. The present study emphasizes the influence of the structure of the fatty acyl moiety of SPM on its association with lipoproteins and/or cell membranes and on its intracellular routing and metabolic degradation.
合成了三种鞘磷脂(SPM)的荧光类似物,每种在脂肪酰基残基中都含有芘,并用于研究它们被完整培养的人皮肤成纤维细胞摄取的方式以及在细胞内的降解情况。这些类似物是通过使鞘氨醇磷酸胆碱与以下脂肪酸缩合制备的:芘十二烷酸(P12)、芘磺酰氨基十一烷酸(PSA11)和芘丙酸(P3:1)。研究了正常、尼曼 - 匹克病A型和低密度脂蛋白(LDL)受体阴性家族性高胆固醇血症成纤维细胞对这些SPM类似物的细胞结合和分解代谢情况,并与[胆碱甲基 - 14C]鞘磷脂的代谢进行了比较。通过测量相应荧光神经酰胺的出现来监测荧光衍生物的分解代谢。观察到两种摄取和降解模式。因此,当与含血清培养基一起孵育时,P12 - SPM和放射性标记的SPM通过LDL受体介导的内吞作用被摄取,这一结论得到家族性高胆固醇血症成纤维细胞摄取率极低的支持,这些细胞缺乏载脂蛋白B/E受体。摄取后,这些化合物仅通过溶酶体鞘磷脂酶进行代谢降解,尼曼 - 匹克病细胞中超过98%的SPM未降解这一事实证明了这一点。相比之下,PSA11 - SPM和P3:1 - SPM通过不依赖受体的内吞途径被摄取,培养基中有无胎牛血清时,对照细胞和家族性高胆固醇血症细胞的摄取率相似表明了这一点。PSA11 - SPM和P3:1 - SPM的降解主要由溶酶体鞘磷脂酶引起,但也由一个尚未明确的过程引起。后一种分解代谢途径在尼曼 - 匹克病A型成纤维细胞中活跃,似乎不同于在皮肤成纤维细胞匀浆中无法检测到活性的中性Mg2(+)依赖性鞘磷脂酶。本研究强调了SPM脂肪酰基部分的结构对其与脂蛋白和/或细胞膜的结合、细胞内途径和代谢降解的影响。